Atrion Corp (ATRI)
654.80
-15.00 -2.24%
NASDAQ
Apr 19, 16:58
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 147.59M |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 17.44 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 32.12M |
Profitability | |
Gross Profit Margin (Quarterly) | 43.20% |
Profit Margin (Quarterly) | 22.86% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 1.04% |
Price and Valuation | |
Market Cap | 1.197B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 8.168 |
PE Ratio | 37.55 |
Price to Book Value | 4.978 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 0.00 |
Free Cash Flow (Quarterly) | 3.484M |
Return on Equity | Upgrade |
View All ATRI News
News
-
WireHeadlineTime (ET)
-
Yahoo04/12 01:31
-
Yahoo03/07 01:04
-
Yahoo02/27 01:45
-
SA Breaking News02/26 17:58
-
Globe Newswire02/26 17:47
-
SA Breaking News02/26 16:10
-
Globe Newswire02/26 14:50
-
Yahoo01/27 23:32
-
SA Breaking News11/13 16:33
-
Globe Newswire11/13 16:30
-
SA Breaking News11/09 16:55
-
MT Newswires11/09 16:31
-
Globe Newswire11/09 16:30
-
MT Newswires08/20 16:44
-
SA Breaking News08/20 16:33
-
Globe Newswire08/20 16:30
-
MT Newswires08/07 09:13
-
SA Breaking News08/06 17:21
-
MT Newswires08/06 16:32
-
Globe Newswire08/06 16:30
View All Events
Events
Date | Type | Description |
---|---|---|
05/07/2020 00:00 | Earnings Results | Q1 2020 Earnings Results |
05/21/2020 10:00 CDT | Agm | 2019 Annual General Meeting |
06/12/2020 None | Dividends | 1.55 Normal, declared May 21, 2020 and paid June 30, 2020 |
08/06/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
09/14/2020 None | Dividends | 1.75 Normal, declared August 20, 2020 and paid September 30, 2020 |
11/09/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
11/30/2020 None | Dividends | 1.75 Normal, declared November 13, 2020 and paid December 15, 2020 |
02/26/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
03/12/2021 None | Dividends | 1.75 Normal, declared February 26, 2021 and paid March 31, 2021 |
05/07/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
- URL: http://www.atrioncorp.com
- Investor Relations URL: https://www.atrioncorp.com/investor_relations/Investor_Relations.htm
- HQ State/Province: Texas
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Equity Style: Small Cap/Blend
- Next Earnings Release: May. 07, 2021
- Last Earnings Release: Feb. 26, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 12, 2021
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 654.80 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
DFDSX | DF Dent Small Cap Growth Investor | 2.70% |
PKSCX | Virtus KAR Small-Cap Core C | 1.73% |
RNSC | First Trust Small Cap US Equity Sel ETF | 1.25% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ATRI Tweets Stocktwits
Advertisement